Synvisc-One Hyaluronic Acid Knee Injection from Japan
Synvisc-One is a single-dose viscosupplement containing hylan G-F 20, a derivative of hyaluronic acid sodium salt, for osteoarthritis knee pain relief. Classified under HTS 3004.90.10.00 due to its hyaluronic acid content in pre-filled syringes for therapeutic administration.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include batch certificates and stability data to prove product integrity
• Comply with USP <797> standards for sterile injectables during import validation
• Avoid misdeclaration as cosmetic filler to prevent duty evasion penalties